showed a trendp=0.068
The H group showed a trend towards reduced blood loss in the second, TXA-treated leg (p=0.068), indicating a potential benefit of TXA administration in the second stage.
The H group showed a trend towards reduced blood loss in the second, TXA-treated leg (p=0.068), indicating a potential benefit of TXA administration in the second stage.
Although there was a trend towards reduced blood loss with TXA, the difference did not reach statistical significance (p=0.070).